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Effects of ionising radiation on extracellular matrix (ECM)-modulated cell survival and on adhesion and invasion are not well
understood. In particular, the aggressiveness of glioblastoma multiforme has been associated with tumour cell invasion into adjacent
normal brain tissue. To examine these effects in more depth, four human glioblastoma cell lines (A-172, U-138, LN-229 and LN-18)
were irradiated on fibronectin (FN), Matrigel, BSA or polystyrene. Major findings of this study include a significantly increased survival
of irradiated A-172 but not of irradiated U-138, LN-229, and LN-18 cells on FN or Matrigel compared to cells irradiated on
polystyrene or BSA. Irradiation induced a dose-dependent increase in functional b1- and b3-integrins in all four glioma cell lines. This
integrin induction caused improved cell adhesion to FN or Matrigel. In contrast to U-138, LN-229 and LN-18 cells, irradiation strongly
impaired A-172 cell invasion. Invasion of all cell lines was inhibited by anti-integrin antibodies, the disintegrin echistatin and the MMP-
2/-9 inhibitor III. Additionally, b1- and b3-integrins modulated basal and radiation-altered gelatinolytic activity of MMP-2. Tested
glioblastoma cell lines showed a differential cellular susceptibility to FN or Matrigel which affected the cellular radiosensitivity. Three
out of four glioma cell lines demonstrated a combination of a substratum-independent survival after irradiation and an invasive
potential which was not affected by irradiation. b1- and b3-integrins were identified to play a substantial, regulatory role in survival,
adhesion, invasion and MMP-2 activity. Detailed insights into radioresistance and invasion processes might offer new therapeutic
strategies to enhance cell killing of lethal high-grade astrocytoma.
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High-grade astrocytomas such as glioblastoma multiforme (GBMs)
are the most common primary brain tumours in adults (Burger
et al, 1985). In addition to surgical resection, the standard clinical
management of this tumour entity involves radiotherapy with or
without adjuvant chemotherapy (Kristiansen et al, 1981; Fisher
et al, 2001; Stupp et al, 2002). In spite of this multidisciplinary
approach, the prognosis for patients with GBM remains poor
(Levin et al, 1997; Galanis and Buckner, 2000).
GBMs are characterised by massive and diffuse infiltration of the
surrounding normal brain tissue and they rarely metastasise to
peripheral organs (Kleihues et al, 1993). These findings suggest
distinctive mechanisms but not distinctive key molecules that
regulate cell invasion of brain tumour cells. Important key
molecules that enable cell invasion are extracellular matrix
(ECM)-degrading enzymes (Liotta and Stetler-Stevenson, 1990;
Stetler-Stevenson et al, 1993) like matrix metalloproteinases
(MMPs) (Ennis and Matrisian, 1994), cathepsin family proteases
(Rochefort, 1994) and plasminogen activators (Mignatti and
Rifkin, 1996). To date, 26 different MMPs are known and GBMs
frequently show an elevation of various MMPs (Gokaslan et al,
1998; Nakano et al, 1995). In particular, MMP-2 (Brooks et al,
1996) and MMP-9 (Rao et al, 1993) render critical for glioma cell
invasion. Additionally, irradiation was found to induce the
catalytic activity, mRNA and protein synthesis of MMP-2
(Engebraaten et al, 1992; Bauman et al, 1999; Wild-Bode et al,
2001). The clinical consequences and interpretation of these
findings for glioma cell migration and invasion remain contro-
versial.
To invade a cell requires both specific ECM-degrading
proteinases and specific cell surface receptors of the integrin
family (Albelda, 1993; Hynes, 2002). Integrins comprise a large
group of at least 24 different heterodimeric transmembrane
receptors that govern cell–ECM interactions (Hynes, 2002). Each
heterodimer consists of one a- and one b-chain. Integrins are
involved in the regulation of several cell functions such as
differentiation, cell cycle progression, apoptotic pathways and
DNA repair mechanisms (Adams and Watt, 1990; Assoian, 1997;
Hazlehurst et al, 2001). To date avb3 (Brooks et al, 1996; Rooprai
et al, 1999), a5b1 (Ohnishi et al, 1998) and other b1-integrin
combinations (Paulus et al, 1993; Chintala et al, 1996; Friedlander
et al, 1996) have been identified to participate in cell migration and
invasion. The role of the avb3-integrin for migration has been
examined in detail and evidence was provided that this integrin
has a dual function. It is a binding receptor for ECM proteins and
it serves as a receptor for MMP-2 on the cell surface (Brooks et al,
1996). These interactions facilitate conversion of pro-MMP-2 to
active MMP-2 thereby controlling both migration and proteolytic
cleavage of ECM components. Similarly, b1-integrins have also
been uncovered to control the expression and activity of MMP-2
(Ellerbroek et al, 1999) and MMP-9 (Troussard et al, 2000).
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sIn addition to cell invasion, interactions between cells and the
ECM regulate survival and proliferation (Meredith et al, 1993;
Schwartz, 2001). Previously, we showed an ECM-dependent
reduction of the cellular radiosensitivity, termed cell adhesion-
mediated radioresistance (CAM-RR), in a variety of malign and
normal cell lines (Cordes and Meineke, 2003; Cordes and van
Beuningen, 2003). We also reported a radiation-induced upregula-
tion of functional b1-integrins in human lung cancer cell lines that
strongly improved adhesion to fibronectin (FN) or laminin
(Cordes et al, 2002, in press (a), (2003)).
To further define the interactions of irradiation and b1-, b3-
integrin and MMP-2, ECM-mediated cell survival and b1- and b3-
integrin-dependent cell adhesion and invasion was examined in
four human glioma cell lines with different invasive and
tumourigenic potentials.
MATERIALS AND METHODS
Cells
A-172 cells were deposited from DJ Giard and U-138 cells were
from the German Cancer Research Centre in Heidelberg. Both cell
lines were found to form colonies in semisolid medium but were
not tumorigenic in immunosuppressed mice. LN-229 and LN-18
cells were established from de Tribolet and both cell lines were
found to form tumours in nude mice. All glioblastoma cell lines
used were purchased from the American Type Culture Collection
(ATCC, Rockville, MD, USA). Dulbecco’s modified Eagle’s medium
(DMEM; GIBCO, Germany) supplemented with 10% foetal bovine
serum (FBS; PAA, Austria) and 1% nonessential amino acids
(GIBCO, Germany) was applied to culture the cells routinely at
371C in a humidified atmosphere containing 10% CO2 buffered at
pH 7.35. Where indicated, serum starvation of cells was performed
using DMEM supplemented with 1% nonessential amino acids
without FBS. For all experiments asynchronous, exponentially
growing cell cultures were employed.
Radiation exposure
Irradiation was delivered at room temperature using single doses
of 240kV X-rays (Isovolt 320/10; Seifert, Germany) filtered with
3mm Be. The absorbed dose was measured using a Duplex
dosimeter (PTW, Germany). The dose rate was approximately
1Gymin
 1 at 13mA. Applied doses ranged from 0 to 8Gy.
siRNA transfection
The sequence of b1- and b3-integrin siRNA was selected based on
a method described previously (Elbashir et al, 2002). The target
sequence that effectively mediates silencing of b1-integrin expres-
sion is 50-AATGTAACCAACCGTAGCA-30 and of b3-integrin
expression is 50-CAAGCCTGTGTCACCATAC-30 (sense se-
quences). The 21-nucleotide synthetic siRNA duplex was prepared
by MWG (Germany) based on Dharmacon 20-ACE technology. A-
172 and U-138 cells were transfected with the b1- or b3-integrin
siRNA or a 21-nucleotide irrelevant RNA Duplex II as a control
using oligofectamine (Invitrogen, Germany). Depletion of b1- and
b3-integrin was confirmed by Western blotting.
Colony formation assay
The colony formation assay was applied for measurement of
clonogenic cell survival. Cells were plated onto polystyrene
(Falcon, Germany) or FN (Becton Dickinson, Germany), Matri-
gel
s-Matrix (Becton Dickinson, Germany) or bovine serum
albumin (BSA; Sigma-Aldrich, Germany) precoated six-well dishes
(Falcon, Germany). Culture plates and flasks were coated with
1mgcm
 2 FN or BSA or 100mgml
 1 Matrigel in serum-free
medium for 1h at room temperature. SiRNA-transfected A-172
and U-138 cells were seeded on polystyrene and irradiated with 2
or 6Gy. Cells were exposed to radiation 24h after plating. At 8–10
days after irradiation, grown colonies were stained with Coomassie
blue. Colonies greater 50 cells were counted. All experiments were
repeated three times.
Flow cytometry
Determination of b1- and b3-integrin cell surface expression was
performed as published elsewhere (Cordes et al, 2002). Shortly,
subconfluent monolayer cell cultures (B60% confluence) attached
to polystyrene, FN or Matrigel were irradiated with 2 or 6Gy,
detached with trypsin/EDTA at defined time points (0, 12, 24, 36,
48h) and prepared for measurements. Nonirradiated controls were
prepared in parallel at each time point. Staining with FITC-
conjugated anti-b1-integrin IgG antibodies (Dako, Germany) or
anti-b3-integrin antibodies (Pharmingen, Germany) was achieved
for 1h at room temperature. Isotype IgG control was from Serotec
(Germany) and secondary FITC-conjugated anti-mouse antibodies
were from Dianova (Germany). Finally, prepared cells were
measured using a Fluorescence-Activated Cell Sorter (FACSCali-
bur; Becton Dickinson, Germany) equipped with the CELLQuest
software. Experiments were repeated three times.
Adhesion assay
The cell adhesion to FN, Matrigel, BSA or polystyrene was studied
according to a method described previously (Cordes et al, 2002). In
brief, 96-well plates (Nunc, Germany) were coated with 1mgcm
 2
FN or BSA or 100mgml
 1 Matrigel in serum-free medium for 1h
at room temperature. At 48h postirradiation, 5x10
4 nonirradiated,
irradiated (6Gy) or siRNA-transfected cells grown on polystyrene
were washed, trypsinised and plated onto prepared wells in the
absence or presence of adhesion-blocking b1-integrin antibodies
(mAb13, 10mgml
 1, Pharmingen, Germany), adhesion-blocking
b3-integrin antibodies (RUU-PL7F12, 10mgml
 1, Pharmingen,
Germany) or the b1/b3-integrin-blocking disintegrin echistatin
(10mM, Sigma-Aldrich, Germany) (Staiano et al, 1995). Unspecific
IgG2a (Upstate, Germany) and IgG1 (Pharmingen, Germany)
antibodies were employed for control experiments using identical
concentrations as done for specific antibodies. After 45min
incubation at 371C, nonadherent cells were withdrawn by gentle
washing with PBS. Adherent cells were fixed with 70% ethanol and
stained using 1% methylene blue. Washing with distilled water was
followed by the addition of 100ml of an 0.1 M HCl solution to each
well and measurement of absorbance of the resulting solution at
630nm using a spectral-photometer (Spectra max
s 190, molecular
devices, Germany). All experiments were performed in triplicate
and repeated three times.
In vitro invasion assay
The potential of invasion of nonirradiated and irradiated (6Gy) as
well as siRNA-transfected cells into Matrigel was determined by
the use of polycarbonate filters (8-mm pore size; Becton Dickinson,
Germany) coated with growth factor-reduced Matrigel placed in a
modified Boyden chamber. Cells (2.5x10
4) were added to the top
chamber. Top and bottom chambers contained media with 10%
FBS. This experimental set-up was chosen according to the flow
cytometric analysis of b1- and b3-integrins to enable direct
evaluation of the role of b1- and b3-integrins for cell invasion.
After a 24-h time interval, the FBS-containing medium was
changed to serum-free medium shortly prior to irradiation with
6Gy. At 48h post radiation, which presented the time point of b1-
and b3-integrin upregulation, cells in the top chamber were
incubated with 25mM MMP-2/-9 inhibitor III (Calbiochem-
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sNovabiochem, Germany) (Koivunen et al, 1999), 10mgml
 1 anti-
b1-integrin antibodies mAb13, 10mg/ml
 1 anti-b3-integrin anti-
bodies RUU-PL7F12 or 10mM b1/b3-integrin-blocking echistatin
for 15min. Unspecific IgG2a and IgG1 antibodies were employed
for control experiments using identical concentrations as done for
specific antibodies. Replacing serum-free medium in the lower
chamber with 10% FBS-containing medium started the assay. After
24h, noninvaded cells were wiped off the top surface of the
membrane filter with a cotton swap and filters were removed.
Invaded cells were fixed with 70% ethanol and 4% paraformalde-
hyde, stained with Coomassie blue and enumerated in four high-
powered fields using a Leitz Diaplan microscope (Bensheim,
Germany;  10 magnification). Cells were counted twice by two
independent observers (NC and BH). Interobserver variation was
o 5%.
Total protein extracts and Western blotting
Nonirradiated or irradiated cells (6Gy) were harvested with
trypsin/EDTA 48h postirradiation. Subsequent to resuspension
of cells in ice-cold medium, centrifugation at 41C and washing with
ice-cold PBS, cells were lysed using modified RIPA buffer
containing 50mM Tris-HCl (pH 7.4), 1% NP-40, 0.25% sodium
deoxycholate, 150mM NaCl, 1mM EDTA supplemented with
protease inhibitor cocktail complete
s (Roche, Germany), 5mM
sodium vanadate and 5mM sodium fluoride. Cell homogenisation
was performed with a 25-gauge needle. Total protein extracts were
stored at –1341C until use. SiRNA-transfected cells were lysed with
RIPA buffer 48h after transfection. Total protein extracts (20mg)
were separated by SDS – polyacrylamide electrophoresis on 10%
(MMP-2, MT1-MMP, b1-integrin, b3-integrin) or 15% (TIMP-2)
gels. Transfer of separated proteins onto a nitrocellulose
membrane (Schleicher & Schuell, Germany), blocking membranes
with 5% nonfat dry milk powder in PBS and incubation of primary
antibodies at 41C overnight were followed. The following
antibodies were used: anti-MMP-2 (1:500), anti-MT1-MMP
(1:500), anti-TIMP-2 (1:40) (Oncogene, Germany), anti-b1-
integrin (1:500), anti-b3-integrin (1:500) (Transduction Labora-
tories, Germany) and anti-b-actin (1:2000) (Sigma-Aldrich,
Germany). The protein detection was accomplished using specific
horseradish peroxidase-conjugated goat antimouse antibodies
(Santa Cruz, Germany) in combination with the enhanced
chemiluminescence detection system (ECL, Amersham, Life
Sciences, Germany).
Immunofluorescence staining and laser confocal scanning
microscopy
Immunofluorescence staining was performed as described else-
where (Cordes et al, 2002). In brief, 5x10
3 A-172 or U-138 cells
were seeded onto Lab Tek chamber slides (Nalge Nunc Interna-
tional, Germany). After a 24-h incubation of cells at 371Ci na
humidified atmosphere containing 10% CO2, cells were fixed using
2% paraformaldehyde in PBS and blocked with 2% goat serum.
Staining of cells with anti-b1-integrin (Dako, Germany) and anti-
MMP-2 (Oncogene, Germany) antibodies was performed for 1h at
room temperature at a dilution of 1:150 and 1:150, respectively.
Secondary antibodies, Cyt2-conjugated AffiniPure goat anti-
mouse IgG and Cyt3-conjugated AffiniPure goat anti-rat IgG
were used at a dilution of 1:100 (Dianova, Germany). Fluorescence
images were obtained using a confocal laser scan microscope
equipped with TCS NT software (LEICA Instruments, Germany).
Gelatine assay
Conditioned, serum-free media from nonirradiated or irradiated
(6Gy) cells were collected 48h after irradiation, centrifuged to
remove corpuscular material, snap frozen in liquid nitrogen and
stored at –1341C until use. In parallel, cells were counted to enable
analysis of MMP activity per cell number. Dependence of MMP
activities on b1- and b3-integrins was also examined in cells
incubated with 10mg/ml
 1 anti-b1-integrin antibody mAb13,
10mg/ml
 1 anti-b3-integrin antibody RUU-PL7F12 or 10mM
echistatin without or in combination with 25mM MMP-2/-9
inhibitor III for 15min in serum-free medium prior to irradiation
(6Gy). Unspecific IgG2a and IgG1 antibodies were employed for
control experiments using identical concentrations as done for
specific antibodies. Media equal to 1.1 10
4 cells were electro-
phoresed on 10% SDS-gels copolymerised with 0.1% gelatine.
Subsequently, gels were washed twice in 50mM Tris-HCl (pH 7.5)/
2.5% Triton X-100 for 30min, incubated overnight at 371C with
50mM Tris-HCl (pH 7.6), 10mM CaCl2, 150mM NaCl and 0.05%
NaN3, stained with Coomassie blue and destained to identify the
zones of lysis.
Data analysis
Means plus/minus standard deviations of surviving fractions and
flow cytometric analysis of b1- and b3-integrin expression were
calculated with reference to untreated controls defined as 1.0. To
test statistical significance, analysis of variance was performed by
means of ANOVA with a software package (Microsoft, Excel 97) on
IBM computer systems. Results were considered statistically
significant or highly significant if P-value of less than 0.05 or
0.01 was reached, respectively. The fit of the dose – effect curves
was calculated using the linear–quadratic model
(logS¼ aD bD
2).
RESULTS
ECM presence differentially affected cell survival after
irradiation
Clonogenic survival was determined to measure substratum-
dependent cell survival after irradiation.
The survival of A-172 cells was significantly (Po0.01) improved
following radiation doses Z4Gy when grown on FN or Matrigel
(Figure 1A). In contrast, irradiation of U-138, LN-229 and LN-18
cells adhered to FN or Matrigel resulted in surviving fractions
similar to cells grown on polystyrene (Figure 1A). Attachment of
cells to BSA reduced survival most effectively after irradiation in
all four cell lines tested.
Silencing of b1- or b3-integrin expression by siRNA transfection
of A-172 and U-138 cells resulted in significantly (Po0.01)
reduced surviving fractions after 2 (SF2) or 6Gy (SF6) compared
to the SF2 and SF6 of untransfected cells as plotted in Figure 1A
(Figure 1B). While the SF2 of A-172 and U-138 cells was
dramatically decreased after double depletion of b1- and b3-
integrin expression, the SF6 could not be determined due to
complete cell killing (Figure 1B). Control siRNA transfections with
unspecific Duplex II showed no significant cytotoxicity compared
to untransfected cells (Figure 1B).
Irradiation induced b1- and b3-integrin cell surface
expression
To confirm previous findings that show radiation-induced integrin
expression (Cordes et al, 2002, 2003), the glioblastoma cell lines
were irradiated and the cell surface expression of b1- and b3-
integrins was measured by FACS.
Irradiation induced a significant and dose-dependent increase in
b1- and b3-integrin cell surface expression in A-172 and U-138
cells (Figure 2).
At 48h after 2Gy, b1-integrins of A-172 or U-138 cells were
increased by 1.3-/1.26-/1.26-fold or by 1.1-/1.1-/1.26-fold (FN/
Matrigel/polystyrene), respectively, compared to unirradiated
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scells. At 48h after 6Gy, b1-integrins of A-172 or U-138 cells were
significantly (Po0.01) increased by 1.72-/1.6-/1.6-fold or by 1.3-
(not significant)/1.37-(Po0.05)/1.73-fold (FN/Matrigel/polystyr-
ene), respectively, compared to unirradiated cells.
At 48h after 2Gy, b3-integrins of A-172 or U-138 cells were
significantly (Po0.01) elevated by 1.73-/2.25-/2.82-fold or by 1.65-/
1.59-/1.6-fold (FN/Matrigel/polystyrene), respectively, compared
to unirradiated cells. At 48h after 6Gy, b3-integrins of A-172 or U-
138 cells were also significantly (Po0.01) elevated by 2.31-/2.39-/
3.39-fold or by 1.92-/1.89-/2.22-fold (FN/Matrigel/polystyrene),
respectively, compared to unirradiated cells.
According to the experimental conditions used in the in vitro
invasion assay and the gelatine zymography, b1- and b3-integrin
expression of A-172 and U-138 cells was also examined under
serum-free conditions. The results obtained were not significantly
different from those results generated in nonirradiated or
irradiated cells grown with serum (data not shown).
Adhesion to FN and Matrigel was significantly improved
after irradiation
Adhesion experiments were performed to prove a normal adhesive
function of basal and radiation-induced integrins. Additionally, it
is shown that the radiation-dependent increase in integrin cell
surface expression improves cell adhesion.
Attachment of nonirradiated A-172 and U-138 cells to FN or
Matrigel was several fold greater than attachment to polystyrene or
BSA (Figure 3). Blocking of b1-integrins with specific antibodies
impaired adhesion to FN more effectively than adhesion to
Matrigel. In contrast, the anti-b3-integrin antibodies more
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Figure 1 (A) Plating human A-172, U-138, LN-229 or LN-18
glioblastoma cells on FN, Matrigel, polystyrene or BSA differentially altered
the cellular radiosensitivity. Survival of A-172 cells grown on FN or Matrigel
was significantly (Po0.01) improved at doses X4Gy. In contrast, irradiated
U-138, LN-229 or LN-18 cells showed no substratum-dependent
alteration of cell survival. Each data point represents the mean 7s.d. of
three independent experiments (n¼18). (B) The surviving fractions after 2
(SF2) or 6 Gy (SF6) of A-172 and U-138 cells were significantly (Po0.01)
reduced after single or combined b1- and b3-integrin depletion using
siRNA transfection (see Western blot) as compared to irradiated cells
transfected with unspecific Duplex II RNA (DII). Single Duplex II RNA
(Unirr. DII) did not significantly reduce the plating efficiency of A-127 and
U-138 cells. * Po0.01.
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Figure 2 48-h flow cytometric analysis of b1- and b3-integrin cell surface
expression in nonirradiated and irradiated A-172 and U-138 cells showed a
dose-dependent induction of these two integrin receptors. Each data point
represents the fold induction (mean 7s.d. of three independent
experiments) of irradiated samples in comparison with unirradiated
controls. P, polystyrene; FN, fibronectin; M, Matrigel.
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seffectively impaired adhesion to Matrigel than adhesion to FN. The
anti-b1/b3-disintegrin echistatin blocked adhesion to both FN and
Matrigel (Figure 3).
At 48h postirradiation which represented the time point of
significant radiation-dependent upregulation of b1- and b3-
integrins, adhesion of irradiated A-172 cells to FN or Matrigel
was significantly (Po0.01) increased. U-138 cells only showed
significantly (Po0.01) increased adhesion to Matrigel (Figure 3).
Blocking integrins with indicated antibodies in irradiated A-172
and U-138 cells showed similar results as obtained in unirradiated
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Figure 3 Radiation (6Gy) improved the capability of A-172 and U-138 cells to attach to fibronectin (FN) and Matrigel after 48h in comparison with BSA
or polystyrene (P). To determine functional b1- and b3-integrin engagement in radiation-altered adhesion in these two cell lines, the cells were incubated
with specific adhesion-blocking antibodies against b1- (mAb13) or b3-integrins (RUU-PL7F12) or with the disintegrin echistatin. Control experiments were
performed using equivalent concentrations of unspecific anti-mouse IgG2a or IgG1 antibodies. Columns represent the mean 7s.d. of the optical densities
(OD) at 630nm representing cell adhesion to the different substrates of three independent experiments. Statistical analysis compared adhesion to FNo r
Matrigel of nonirradiated cells with adhesion to FN or Matrigel of irradiated cells. * Po0.01.
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Matrigel of nonirradiated or irradiated cells.
siRNA treatment of A-172 and U-138 cells against b1- or b3-
integrins caused a strong impairment of adhesion to FN and
Matrigel comparable to the adhesion of untransfected cells to
polystyrene. Combined depletion of both integrins completely
prevented adhesion of both cell lines to polystyrene, FN or
Matrigel (data not shown).
Irradiation differentially affected cell invasion into
Matrigel
Invasion is one of the major pathophysiological characteristics of
glioblastoma cells. To evaluate the impact of irradiation on the
invasive potential and the impact of the radiation-dependent
increase of b1- and b3-integrins of the cell lines examined, the
Matrigel in vitro invasion assay was performed.
The basal invasive potential of A-172 and U-138 cells into
Matrigel differed by seven-fold (Figure 4). Treating cells with the
MMP-2/-9 inhibitor III reduced invasion by 3- (A-172) or 1.8-fold
(U-138). Treatment of cells with anti-b1- or anti-b3-integrin
antibodies or echistatin reduced invasion significantly (Po0.01)
by 10- (A-172) or 4-fold (U-138) compared to untreated controls.
Combined exposure using either MMP inhibitor plus anti-integrin
antibodies or MMP inhibitor plus echistatin further decreased the
degree of invasion in comparison to the single treatment
conditions. Comparing LN-229 and LN-18 cells to U-138 cells,
great similarity could be observed concerning their basal invasive
potentials and their behaviour after treatment with MMP inhibitor
and anti-integrins (Figure 4). These findings indicated a coopera-
tion between MMP-2 and b1- and b3-integrins in the invasion of
the tested cell lines (Figure 4).
Following irradiation, invasion of A-172 cells was impeded by
26-fold, whereas U-138, LN-229 and LN-18 cell invasion was not
affected (Figure 4). Pretreatment of irradiated A-172 and U-138
cells with anti-integrins alone or with anti-integrins plus MMP
inhibitor reduced the rate of invasion similar to the effects seen in
treated, nonirradiated cells (Figure 4).
Following siRNA transfection, invasion of both A-172 and U-138
cells into Matrigel was strongly reduced by 495%. These results
were independent of single or double b1/b3-integrin depletion
(data not shown).
Expression of MMP-2, MT1-MMP and TIMP-2 was affected
by IR and anti-integrin treatment
Protein expression profiles of the important ECM-degrading
proteinases MMP-2 and MT1-MMP and the antagonist TIMP-2
were determined to estimate changes in MMP-2 activity after
radiation or treatment with anti-integrins or MMP-2/-9 inhibitor
III more precisely.
Irradiation strongly induced MMP-2 and MT1-MMP expression
in A-172 and U-138 cells (Figure 5). While anti-integrin antibodies
or echistatin prevented this radiation-dependent upregulation of
MMP-2 and MT1-MMP expression, MMP-2/-9 inhibitor III had no
effect. TIMP-2 expression decreased after irradiation and was
stabilised by anti-integrin treatment (Figure 5).
b1-integrins colocalised with MMP-2 at distinct regions of
the cell membrane
To confirm reported observations about membranous b1-integrin-
MMP-2 colocalisation at sites called focal adhesions which
represent the structural and signalling correlate that connect the
ECM to the cytoskeleton, confocal scanning microscopy was
performed.
The fluorescence signals of b1-integrins in combination with
MMP-2 colocalised at these specific membrane regions termed
focal adhesions and in the cytoplasm (Figure 6). In control
experiments using the secondary antibodies, no fluorescence
signals could be detected. Similar results were obtained in LN-
229 and LN-18 cells (data not shown).
Gelatinolytic activity of MMP-2 was strongly modulated by
irradiation, anti-integrins and MMP-inhibitor
The gelatinolytic activity of MMP-2, an important matrix-cleaving
proteinase, was measured to define the effects of radiation and
anti-integrins or MMP inhibitor treatment with regard to cell
invasion in more detail.
Basal MMP-2 activity was reduced by MMP-2/-9 inhibitor III in
both cell lines (Figure 7A and B). Treatment of cells with anti-
integrins showed an induction of pro-MMP-2 (Mr 66000) and an
increased conversion of pro-MMP-2 to the active form (Mr 62000)
(Figure 7A and B). These findings were likely to be due a
stimulation of integrins and their signalling pathways by the
employed antibodies.
Irradiated A-172 (Figure 7A) and U-138 (Figure 7B) cells showed
increased gelatinolytic activity of MMP-2 within 48h. While the
MMP inhibitor slightly reduced the conversion of MMP-2 to its
active form in irradiated A-172, it demonstrated to be less effective
in irradiated U-138 cells. The radiation-induced MMP-2 activity
and the enhancement of MMP-2 conversion was prevented by anti-
b1- and anti-b3-integrin antibodies or echistatin in both cell lines.
Treatment of cells with the combination of anti-integrin antibodies
plus MMP-2/-9 inhibitor III resulted in similar data as shown for
nonirradiated or irradiated controls (data not shown). Exposure of
A-172 (Figure 7A) and U-138 cells (Figure 7B) with unspecific
IgG2a and IgG1 control antibodies did not prevent radiation-
dependent induction of MMP-2 activity as observed in untreated,
irradiated cells.
Depleting b1- or b3-integrins by siRNA transfection of A-172
and U-138 cells strongly decreased MMP-2 activity. A combined
depletion of b1- plus b3-integrins presented most effective in
reducing the gelatinolytic activity of MMP-2 (Figure 7A and B).
DISCUSSION
Effects of irradiation on ECM-modulated cell survival as well as on
adhesion and invasion are not well understood. Major findings of
this study include: (i) a significantly reduced radiosensitivity of A-
172 but not of U-138, LN-229 and LN-18 cells grown on FN or
Matrigel compared to cells grown on polystyrene or BSA; (ii) a
significantly induced upregulation of functional b1- and b3-
integrins by irradiation that could be correlated with improved b1-
and b3-integrin-mediated adhesion to FN or Matrigel; (iii) strong
invasion-inhibiting effects of irradiation on A-172 cells in contrast
to U-138, LN-229, and LN-18 cells; (iv) a modulating role of b1-
and b3-integrins on the gelatinolytic activity of MMP-2 without
and in combination with irradiation; and (v) siRNA transfection
data that strongly underlined b1- and b3-integrins as key
molecules in glioma cell survival, adhesion, and invasion.
The examination of various transformed cell lines and primary
cell strains has raised evidence for chemo- and radioprotective
effects of specific ECM proteins (Vlodavsky et al, 1980; Fuks et al,
1992; Rose et al, 1999; Hazlehurst et al, 2001; Cordes et al, 2002 in
press (a), 2003; Cordes and Meineke, 2003; Cordes and van
Beuningen, 2003). As reported (Bouterfa et al, 1999; Oz et al, 2000;
Mahesparan et al, 2003), FN, laminin, collagen-IV and -I, decorin,
tenascin and vitronectin are ECM proteins produced and secreted
by cells of malignant tumours of glial origin in vitro and in vivo.
Although it is difficult to correlate heterogeneous ECM protein
expression patterns in the same or among different tumours and
migratory and invasive behaviour, the findings suggest that glioma
cells are able to modulate their microenvironment thus affecting
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Figure 4 The in-vitro invasion assay indicated that irradiation (6Gy) is able to inhibit strongly A-172 but not U-138, LN-229 and LN-18 cell invasion into
Matrigel. To analyse the dependence of the invasion process on MMP-2 or b1- or b3-integrins, nonirradiated as well as irradiated cells were either incubated
with the MMP-2/-9 inhibitor III (MI), anti-b1- (mAb13) and anti-b3-integrin (RUU-PL7F12) antibodies or the b1-/b3-integrin-blocking disintegrin echistatin
alone or in combination. Additionally, control experiments were performed using equivalent concentrations of unspecific anti-mouse IgG2a or IgG1
antibodies. The data were collected by counting the number of cells per field (four high-powered fields). Columns represent the calculated mean 7s.d. of
three independent experiments. Statistical significance was calculated by comparing the rate of invasion after anti-MMP and/or anti-integrin treatment to the
rate of invasion of untreated cells. Furthermore, statistics were calculated by comparing the rate of invasion of treated cells after irradiation to the rate of
invasion after irradiation alone. nt, no treatment; *Po0.01.
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ssurvival, migration and invasion. Clonogenic survival data
generated in the glioma cell line A-172 grown on FN or the
basement membrane matrix equivalent, Matrigel, confirmed that
certain glioma cell lines are affected by matrix proteins. This
results in an adhesion-mediated radioprotective effect in vitro. The
cellular susceptibility to matrix proteins seems to be a prerequisite
for the modulation of the intrinsic cellular radiosensitivity. For
adhesion to artificial and physiological surfaces, adherent growing
cells recruit cell adhesion molecules. However, in case of adhesion
to a physiological ECM protein many, if not all, cell functions are
specifically modified by integrin-mediated signalling (Albelda,
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-actin 
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Figure 5 Western blot analysis of MMP-2, MT1-MMP and TIMP-2 in
nonirradiated (co) and irradiated cells showed that irradiation induced
MMP-2 and MMT1-MMP expression within 48h. Treatment of cells with
MMP-2/-9 inhibitor III (MI), anti-b1- (mAb13) or anti-b3-integrins (RUU-
PL7F12, RUU) or echistatin (Echi) prevented induction of MMP-2 and
MT1-MMP and promoted induction of TIMP-2 after irradiation. In contrast,
TIMP-2 expression was downregulated after irradiation and induced by
anti-integrin treatment. nt, no treatment.
1-integrin MMP-2 Merged
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Figure 6 Double immunofluorescence staining of b1-integrin plus MMP-
2 in A-172 and U-138 cells. b1-integrin and MMP-2 were visualised by
confocal scanning microscopy after fixing and staining of cells with the
appropriate antibodies. Arrows indicate b1-integrin plus MMP-2 colocalisa-
tion within focal adhesion sites in the cell membrane. Bar, 10mm.
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Figure 7 Conditioned media of 48-h nonirradiated (co) and irradiated
A-172 (A) or U-138 (B) cells were analysed on 10% PAGE-gelatine. Effects
of MMP-2/-9 inhibitor III (MI), anti-b1-integrin (mAb13) and anti-b3-
integrin (RUU-PL7F12, RUU) antibodies and the b1-/b3-blocking disin-
tegrin echistatin on the gelatinolytic activity of MMP-2 and its conversion
from the pro (Mr 66000) to the active form (Mr 62000) are shown in
nonirradiated and irradiated cells. Additionally, irradiation control experi-
ments were performed using equivalent concentrations of unspecific anti-
mouse IgG2a or IgG1 antibodies. Following b1- and/or b3-integrin siRNA
transfection of A-172 and U-138 cells, the gelatinolytic activity of MMP-2
was strongly decreased in both cell lines. The combined depletion of both
b1- and b3-integrin had the greatest effect. nt, no treatment; DII, unspecific
Duplex II control.
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s1993; Assoian, 1997; Giancotti and Ruoslahti, 1999; Schwartz
and Assoian, 2001). In particular, survival-improving signalling
has been tightly connected with the widespread integrin subunit
b1 (Meredith et al, 1993; Schwartz, 2001). In contrast to A-172
cells, irradiated U-138, LN-229, and LN-18 cells that were
unsusceptible to the used substrates showed ECM-independent
survival. Specific genomic mutations or post-transcriptional
modifications of molecules that are substantially involved in
cell-matrix-stimulated and survival-advantaging signalling have
to be taken into consideration. Interestingly, the clonogenic
survival data of b1- and b3-integrin depleted A-172 and U-138
cells questions this hypothesis, because both cell lines demon-
strated a great increase in cell killing after irradiation in
comparison with untransfected, irradiated or control Duplex II-
transfected, irradiated cells. With regard to findings of Lewis et al
(2002), who observed adhesion-mediated apoptosis in certain
transformed cell lines after DNA damage, the killing of these
cell lines could be increased by treatment with anti-integrin
antibodies and increased levels of p53 or Arf. The cell lines used in
our study displayed either wild-type p53 (A-172) or mutant p53
(U-138, LN-229, LN-18). Preliminary data from our lab show
that basal p53 expression levels and levels of downstream targets
such as p21 are not altered by the substratum itself on which
cells are growing on (Cordes, 2003, unpublished observation).
FN adhered p53-wild-type cell cultures, for example, normal
human fibroblasts or A549 lung cancer cells, demonstrate delayed
changes of p53 and p21 in response to DNA damage compared to
cell cultures adhered to polystyrene. In contrast to protein
expression, the induction of p53 phosphorylation on serine-20 is
accelerated in FN cultures after irradiation compared to poly-
styrene cultures (Cordes and Beinke, in press). Additionally,
human p53-wild-type fibroblasts or A-172 glioma cells accumulate
more strongly in the G2-phase of the cell cycle after irradiation and
show an improved ECM-dependent radiation survival response.
Further investigations will elucidate whether mutated p53 or Arf
are responsible for the different glioma cell behaviours observed in
this study.
Integrins serve as adhesion receptors to matrix proteins.
Irradiation improved adhesion of A-172 and U-138 cells to FN
or Matrigel through an upregulation of functional b1- and b3-
integrins on the cell surface. Blocking integrins with specific
antibodies or echistatin revealed that attachment of these cells to
FN is mainly mediated by b1-integrins, while attachment to the
basement membrane matrix equivalent, Matrigel, is mainly
enabled by b3-integrins. As these effects were observed in both
nonirradiated and irradiated cells, the integrin recruitment during
adhesion seems to be matrix-specific and not to be influenced by
irradiation. Depletion of b1- and b3-integrins in A-172 and U-138
cells strongly supported these findings and almost completely
abrogated the cell’s adhesive capability.
Adhesion and migration are closely linked cell functions. Thus,
changes in integrin patterns are likely to affect both of these
processes. MMP-2, as integral molecule of the invasion process,
was activated by irradiation in a b1- and b3-integrin-dependent
manner and by stimulating anti-b1- and anti-b3-integrin anti-
bodies. In controversy with the well-known association of the
invasive phenotype with MMP overexpression (Rich et al, 1985;
Ballin et al, 1988), the radiation-mediated MMP-2 induction
(Engebraaten et al, 1992; Nirmala et al, 2000; Wild-Bode et al,
2001) did not lead to increased A-172 and U-138 invasion. Our
controversial data suggest, on the one hand, cell line-specific
interactions between basal gelatinolytic MMP-2 activity and the
degree of invasiveness and, on the other hand, an inverse cell line-
specific interaction between radiation-induced MMP-2 activity and
radiation-dependent impairment of invasion. MMP-2 has been
reported to colocalise with avb3- (Felding-Habermann and
Cheresh, 1993; Brooks et al, 1996) and with b1-integrin (Ellerbroek
et al, 1999). Confocal scanning microscopy of A-172 and U-138
cells confirmed the colocalisation of b1-integrins and MMP-2 at
focal adhesion sites that are the morphological correlates
responsible for structural and regulatory cell–matrix interactions
within, for example adhesion or invasion. Furthermore, the close
proximity of MMPs and integrins at these sites enables direct
coordination of migration and invasion processes. The findings
presented here could be based on a radiation-dependent
modification of b1/b3-MMP-2 interactions as well as intermole-
cular affinities. Our data suggest that b1- and b3-integrin
aggregation and occupancy by specific antibodies block important
cell motility-related receptor epitopes. These events result in a
local anchorage of treated cells. This anchorage is likely to cause a
reduction of MMP-2-specific, membrane-located substrates. We
hypothesise that the radiation-mediated upregulation of MMP-2-
stimulating b1- and b3-integrins in the combination with the
radiation-induced MMP-2 activity promotes a reduction of
MMP-2 substrates. Consequently, the cells are not able to migrate
and invade accordingly. In contrast to A-172 cells which fit into
this model, U-138, LN-229 and LN-18 cells displayed a much
higher basal gelatinolytic MMP-2 activity and lower invasive
potential. Treatment of U-138 cells with the MMP inhibitor
completely failed to inhibit invasion. The phenotype of U-138,
LN-229 and LN-18 cells does therefore rather fit into another
model. As already reported, a high MMP activity is not
consequently bound to a high invasive potential because an
extensive uncontrolled ECM-degradation can impede cell invasion
due to a lack of required matrix components (Ruoslahti, 1992;
Montgomery et al, 1994). Invasion of U-138, LN-229 and LN-18
cells seems to substantially depend on integrin function rather
than on different MMP-2 levels. Further evidence for a direct
cooperation between b1- and b3-integrins and MMP-2 was raised
by silencing of both of these integrins in A-172 and U-138 cells.
The single and combined depletion led to a strong decrease of the
gelatinolytic activity of pro-MMP-2 and a complete loss of its
active form.
Examination of MMP-2, MT1-MMP, a membrane-bound MMP
which is thought to facilitate rapid processing of pro-MMP-2
(Chintala et al, 1999), and TIMP-2 showed that the expression
patterns of MMP-2 and MT1-MMP were very similar among the
examined glioma cell lines. MMP-2 and MT1-MMP were induced
in irradiated cell cultures and they were reduced in irradiated cell
cultures pretreated with anti-integrins. TIMP-2 which preferen-
tially inhibits MMP-2 (Corcoran et al, 1996) showed to be
expressed inversly compared to MMP-2 and MT1-MMP. In LN-
229 and LN-18 cells TIMP-2 was not detectable.
In summary, the presented findings indicate differential radio-
sensitivity-modulating effects of FN and the basement membrane
equivalent matrix mixture, Matrigel, on the glioma cell lines A-172,
U-138, LN-229 and LN-18. Three out of four tested glioma cell lines
demonstrated a combination of a substratum-independent radia-
tion survival response and an invasive potential which was not
affected by irradiation. Furthermore, we can provide a mechanistic
link between b1- or b3-integrins and MMP-2 and may have
implications for models of tumour cell invasion. The role of
radiation-mediated induction of b1- and b3-integrins remains
elusive in detail, but may partly account for altered glioma cell
invasion. Finally, our data might offer a new therapeutic strategy,
in which ligating integrins or inhibiting relevant integrin pathways
may be effective as an adjunct to standard chemo- and radio-
therapy to enforce cell killing and impair cell invasion of lethal
high-grade astrocytoma.
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